Please assess the completion status of the following clinical trial:

Trial Title: Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes~* BMI= 26kg/m2~* Maximal treatment with metformin and sulfonylurea~* HbA1c between 7.5 and 9.5%~Exclusion Criteria:~* Anterior treatment with glitazones~* Anterior treatment with insulin~* Known heart failure~* Hepatopathy~* Renal filtration less than 60ml/min, Hb\<10g/dl~* Corticoids treatment

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): UMULINE NPH at bed time
- 2 (Type: EXPERIMENTAL): pioglitazone 30 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).